Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants

NCT05665647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Cohort 1: SIM0417/ritonavir and itraconazole
DRUG: Cohort 2: SIM0417/ritonavir and rifampicin
DRUG: Cohort 3: SIM0417/ritonavir and midazolam

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.